ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

2015533 citationsJournal Articlebronze Open Access

Authors

Cinicaltrials.gov (identifiers: NCT01623115; NCT01709500).

Good health and well-being

Published in: European Heart Journal

Volume 36, Issue 43, pp. ehv370-ehv370

Field-Weighted Citation Impact: 73.85